Errata: Vol. 60, No. 48

In the report, "Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection," errors occurred. On page 1653, in Box 2, the fourth bullet point should begin, "Baseline hepatic chemistry blood tests (at least alanine aminotransferase [ALT]) for patients with specific conditions:"

On page 1651, in the multination treatment trial described in the second full paragraph, the treating physicians had the option of prescribing oral pyridoxine 50 mg for administration with each dose of both the weekly isoniazid-rifapentine and the daily isoniazid-only regimens. Weekly pyridoxine 50 mg for prophylaxis of isoniazid-associated peripheral neuropathy should be considered with the isoniazid-rifapentine regimen, especially for persons who are malnourished or predisposed by other illnesses to peripheral neuropathy.